Apr 28, 2026 6:00 PM ET | 3:00 PM PT
The speaker will discuss:
-
A novel workflow for low-input spatial proteomics combining immunohistochemistry, artificial intelligence–based image analysis, and laser capture microscopy.
-
The first mass spectrometry–based proteomic study of in vivo–differentiated megakaryocytes in humans.
-
The first study to confirm that megakaryocytes have disease-specific proteomic signatures in classical Philadelphia-negative myeloproliferative neoplasms.
-
Live Q&A—a rare opportunity for direct discussion and troubleshooting.
Register now!
Can’t join live? Register to be notified when the recording is available.
Certificates of attendance are available upon request*.